Intuitive Surgical, Inc. engages in the provision of robotic-assisted surgical solutions and invasive care through a comprehensive ecosystem of products and services. The company is headquartered in Sunnyvale, California and currently employs 17,021 full-time employees. The company went IPO on 2000-06-13. The firm specializes in invasive care and robotic-assisted surgery. Its technologies include the da Vinci surgical systems and the Ion endoluminal system. The da Vinci surgical system is designed to enable surgeons to perform a range of surgical procedures within its targeted general surgery, urologic, gynecologic, cardiothoracic, and head and neck specialties and consists of a surgeon's console or consoles, a patient-side cart, and a high-performance vision system. The Ion endoluminal system is a flexible, robotic-assisted, catheter-based platform for which the cleared indication is minimally invasive biopsies in the lung and consists of a system cart, a controller, a catheter, and a vision probe. Its Ion system extends its commercial offering beyond surgery into diagnostic and endoluminal procedures.

Intuitive Surgical, Inc. terlibat dalam penyediaan solusi bedah yang dibantu robot dan perawatan invasif melalui ekosistem yang komprehensif dari produk dan layanan. Perusahaan berkantor pusat di Sunnyvale, California dan saat ini mempekerjakan 17.021 karyawan penuh waktu. Perusahaan ini melakukan penawaran umum perdana (IPO) pada 13 Juni 2000. Perusahaan ini berspesialisasi dalam perawatan invasif dan bedah yang dibantu robot. Teknologinya mencakup sistem bedah da Vinci dan sistem endoluminal Ion. Sistem bedah da Vinci dirancang untuk memungkinkan ahli bedah melakukan berbagai prosedur bedah dalam spesialisasi bedah umum, urologi, ginekologi, kardiotoraks, dan kepala serta leher yang ditargetkan, dan terdiri dari konsol atau konsol ahli bedah, kereta sisi pasien, dan sistem visi berkinerja tinggi. Sistem endoluminal Ion adalah platform berbasis kateter yang fleksibel dan dibantu robot, yang indikasi yang disetujui adalah biopsi minimal invasif di paru-paru dan terdiri dari kereta sistem, pengontrol, kateter, dan probe visi. Sistem Ion-nya memperluas penawaran komersilnya melampaui bedah ke prosedur diagnostik dan endoluminal.

Intuitive Surgical

Google

Apple

Microsoft

Amazon

Broadcom

Meta Platforms

Eli Lilly

JPMorgan

Oracle

Exxon Mobil

Johnson & Johnson

ASML

MasterCard

SPDR S&P500 ETF

Palantir

Costco

Bank of America

General Electric

Procter & Gamble

Vanguard Total Stock Market ETF

Toyota

Caterpillar

AstraZeneca

Cisco

Goldman Sachs

Lam Research

Wells Fargo

Merck

Novo Nordisk

Novartis

Raytheon Technologies

Philip Morris

Applied Materials

American Express

Royal Bank of Canada

Intel

Abbott

Salesforce

Shell

T-Mobile

Disney

Shopify

Invesco QQQ Trust

Blackstone

PepsiCo

Boeing

Charles Schwab

Amgen

QUALCOMM

Texas Instruments

S&P Global

Verizon

Arista Networks

Lowe's

Capital One

Southern Copper

Honeywell

Sony

Pfizer

Unilever

Deere

TotalEnergies

ServiceNow

Adobe

Palo Alto Networks

ConocoPhillips

Medtronic

Progressive

Chubb

CrowdStrike

Sanofi

Vertex Pharmaceuticals

Bristol-Myers Squibb

Comcast

Vanguard Dev Markets ETF

Mercadolibre

Starbucks

Enbridge

Carvana

Agnico Eagle

General Dynamics

Vanguard Value ETF

Robinhood

Moody's

Nike

Northrop Grumman

Vanguard Total Bond Market ETF

Duke Energy

Scotiabank

Barclays

Doordash Inc

Marsh & McLennan

NetEase

Intuitive Surgical Stock

About Intuitive Surgical

Key Statistics

People Also Bought